102 related articles for article (PubMed ID: 36496180)
1. Functional genomics for curation of variants in telomere biology disorder associated genes: A systematic review.
Nelson N; Feurstein S; Niaz A; Truong J; Holien JK; Lucas S; Fairfax K; Dickinson J; Bryan TM
Genet Med; 2023 Mar; 25(3):100354. PubMed ID: 36496180
[TBL] [Abstract][Full Text] [Related]
2. Refinement of the assignment to the ACMG/AMP BS3 and PS3 criteria of eight
Caleca L; Radice P
Front Oncol; 2023; 13():1146604. PubMed ID: 37168384
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework.
Brnich SE; Abou Tayoun AN; Couch FJ; Cutting GR; Greenblatt MS; Heinen CD; Kanavy DM; Luo X; McNulty SM; Starita LM; Tavtigian SV; Wright MW; Harrison SM; Biesecker LG; Berg JS;
Genome Med; 2019 Dec; 12(1):3. PubMed ID: 31892348
[TBL] [Abstract][Full Text] [Related]
4. Telomere biology disorders may manifest as common variable immunodeficiency (CVID).
Rolles B; Caballero-Oteyza A; Proietti M; Goldacker S; Warnatz K; Camacho-Ordonez N; Prader S; Schmid JP; Vieri M; Isfort S; Meyer R; Kirschner M; Brümmendorf TH; Beier F; Grimbacher B
Clin Immunol; 2023 Dec; 257():109837. PubMed ID: 37944684
[TBL] [Abstract][Full Text] [Related]
5. Using the ACMG/AMP framework to capture evidence related to predicted and observed impact on splicing: Recommendations from the ClinGen SVI Splicing Subgroup.
Walker LC; Hoya M; Wiggins GAR; Lindy A; Vincent LM; Parsons MT; Canson DM; Bis-Brewer D; Cass A; Tchourbanov A; Zimmermann H; Byrne AB; Pesaran T; Karam R; Harrison SM; Spurdle AB;
Am J Hum Genet; 2023 Jul; 110(7):1046-1067. PubMed ID: 37352859
[TBL] [Abstract][Full Text] [Related]
6. Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility.
Johnston JJ; Dirksen RT; Girard T; Hopkins PM; Kraeva N; Ognoon M; Radenbaugh KB; Riazi S; Robinson RL; Saddic Iii LA; Sambuughin N; Saxena R; Shepherd S; Stowell K; Weber J; Yoo S; Rosenberg H; Biesecker LG
Hum Mol Genet; 2022 Nov; 31(23):4087-4093. PubMed ID: 35849058
[TBL] [Abstract][Full Text] [Related]
7. Variant curation expert panel recommendations for RYR1 pathogenicity classifications in malignant hyperthermia susceptibility.
Johnston JJ; Dirksen RT; Girard T; Gonsalves SG; Hopkins PM; Riazi S; Saddic LA; Sambuughin N; Saxena R; Stowell K; Weber J; Rosenberg H; Biesecker LG
Genet Med; 2021 Jul; 23(7):1288-1295. PubMed ID: 33767344
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the impact of in silico predictors on clinical variant classification.
Wilcox EH; Sarmady M; Wulf B; Wright MW; Rehm HL; Biesecker LG; Abou Tayoun AN
Genet Med; 2022 Apr; 24(4):924-930. PubMed ID: 34955381
[TBL] [Abstract][Full Text] [Related]
9. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
[TBL] [Abstract][Full Text] [Related]
10. Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.
Patel MJ; DiStefano MT; Oza AM; Hughes MY; Wilcox EH; Hemphill SE; Cushman BJ; Grant AR; Siegert RK; Shen J; Chapin A; Boczek NJ; Schimmenti LA; Nara K; Kenna M; Azaiez H; Booth KT; Avraham KB; Kremer H; Griffith AJ; Rehm HL; Amr SS; Tayoun ANA;
Genet Med; 2021 Nov; 23(11):2208-2212. PubMed ID: 34230634
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a prospective screening strategy to identify adults with a telomere biology disorder among those undergoing lung transplant evaluation for interstitial lung disease.
Banaszak LG; Smith-Simmer K; Shoger K; Lovrien L; Malik A; Sandbo N; Sultan S; Guzy R; Lowery EM; Churpek JE
Respir Med; 2023 Dec; 220():107464. PubMed ID: 37951311
[TBL] [Abstract][Full Text] [Related]
12. Toward automation of germline variant curation in clinical cancer genetics.
Ravichandran V; Shameer Z; Kemel Y; Walsh M; Cadoo K; Lipkin S; Mandelker D; Zhang L; Stadler Z; Robson M; Offit K; Vijai J
Genet Med; 2019 Sep; 21(9):2116-2125. PubMed ID: 30787465
[TBL] [Abstract][Full Text] [Related]
13. Quantifying the potential of functional evidence to reclassify variants of uncertain significance in the categorical and Bayesian interpretation frameworks.
Brnich SE; Rivera-Muñoz EA; Berg JS
Hum Mutat; 2018 Nov; 39(11):1531-1541. PubMed ID: 30095857
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of DDC variants causing aromatic l-amino acid decarboxylase (AADC) deficiency and pathogenicity interpretation using ACMG-AMP/ACGS recommendations.
Himmelreich N; Montioli R; Garbade SF; Kopesky J; Elsea SH; Carducci C; Voltattorni CB; Blau N
Mol Genet Metab; 2022 Dec; 137(4):359-381. PubMed ID: 36427457
[TBL] [Abstract][Full Text] [Related]
15. APPLICATION OF THE ACMG/AMP FRAMEWORK TO CAPTURE EVIDENCE RELEVANT TO PREDICTED AND OBSERVED IMPACT ON SPLICING: RECOMMENDATIONS FROM THE CLINGEN SVI SPLICING SUBGROUP.
Walker LC; de la Hoya M; Wiggins GAR; Lindy A; Vincent LM; Parsons MT; Canson DM; Bis-Brewer D; Cass A; Tchourbanov A; Zimmermann H; Byrne AB; Pesaran T; Karam R; Harrison S; Spurdle AB
medRxiv; 2023 Feb; ():. PubMed ID: 36865205
[TBL] [Abstract][Full Text] [Related]
16. ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants.
Luo X; Feurstein S; Mohan S; Porter CC; Jackson SA; Keel S; Chicka M; Brown AL; Kesserwan C; Agarwal A; Luo M; Li Z; Ross JE; Baliakas P; Pineda-Alvarez D; DiNardo CD; Bertuch AA; Mehta N; Vulliamy T; Wang Y; Nichols KE; Malcovati L; Walsh MF; Rawlings LH; McWeeney SK; Soulier J; Raimbault A; Routbort MJ; Zhang L; Ryan G; Speck NA; Plon SE; Wu D; Godley LA
Blood Adv; 2019 Oct; 3(20):2962-2979. PubMed ID: 31648317
[TBL] [Abstract][Full Text] [Related]
17. ClinGen Variant Curation Interface: a variant classification platform for the application of evidence criteria from ACMG/AMP guidelines.
Preston CG; Wright MW; Madhavrao R; Harrison SM; Goldstein JL; Luo X; Wand H; Wulf B; Cheung G; Mandell ME; Tong H; Cheng S; Iacocca MA; Pineda AL; Popejoy AB; Dalton K; Zhen J; Dwight SS; Babb L; DiStefano M; O'Daniel JM; Lee K; Riggs ER; Zastrow DB; Mester JL; Ritter DI; Patel RY; Subramanian SL; Milosavljevic A; Berg JS; Rehm HL; Plon SE; Cherry JM; Bustamante CD; Costa HA;
Genome Med; 2022 Jan; 14(1):6. PubMed ID: 35039090
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of functional assay evidence use by ClinGen Variant Curation Expert Panels.
Kanavy DM; McNulty SM; Jairath MK; Brnich SE; Bizon C; Powell BC; Berg JS
Genome Med; 2019 Nov; 11(1):77. PubMed ID: 31783775
[TBL] [Abstract][Full Text] [Related]
19. Expanding ACMG variant classification guidelines into a general framework.
Masson E; Zou WB; Génin E; Cooper DN; Le Gac G; Fichou Y; Pu N; Rebours V; Férec C; Liao Z; Chen JM
Hum Genomics; 2022 Aug; 16(1):31. PubMed ID: 35974416
[TBL] [Abstract][Full Text] [Related]
20. Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria.
Tometten M; Kirschner M; Meyer R; Begemann M; Halfmeyer I; Vieri M; Kricheldorf K; Maurer A; Platzbecker U; Radsak M; Schafhausen P; Corbacioglu S; Höchsmann B; Matthias Wilk C; Hinze C; Chromik J; Heuser M; Kreuter M; Koschmieder S; Panse J; Isfort S; Kurth I; Brümmendorf TH; Beier F
Hemasphere; 2023 May; 7(5):e874. PubMed ID: 37096215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
